Dr Katie KingAcademic
co-founder and chief executive of BioOrbit, PhD in nanomedicine at Cambridge University
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“That becomes really critical for protein drugs, antibody drugs because they are very large and very flexible molecules. So through going to space you see a much better, more superior crystallisation process than what you can achieve here on Earth.”
co-founder and chief executive of BioOrbit, PhD in nanomedicine at Cambridge University · Cancer · 27 Aug 2026 · Final frontier for meds? UK startup sends drug-making into space ↗
Source references
- Final frontier for meds? UK startup sends drug-making into spacetheguardian.com · 27 Aug 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.